Trial intelligence / Profile preview

BIIX 1 XX in Healthy Volunteers (Methacholine Challenge)

NCT02199873Phase 1Completed

Sponsor
Boehringer Ingelheim
Start
Jun 1998
Primary completion
Sep 1998
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial in asthma comparing BIIX 1 XX with Placebo (2 arms). Primary endpoints: Number of subjects with adverse events at 3 months, Number of subjects with abnormal changes in laboratory parameters at 8 days and 2 more. Started Jun 1998; status: completed.

02

Drugs

olodaterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02199873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02199873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call